Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD

NCT05609916 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT05609916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05609916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD
Lead sponsor
Baylor College of Medicine
Phase
Not applicable
Overall status
Recruiting
Start date
November 30, 2022
Completion date
August 30, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive behavioral therapy, obsessive-compulsive disorder, obsessive-compulsive disorder in adolescence, obsessive-compulsive disorder in children